Opinion|Videos|September 6, 2024
Optimizing Pneumococcal Vaccination Efforts in High-Risk Patients
The key opinion leaders explore effective methods for educating patients about pneumococcal vaccination, highlighting its importance and benefits, while also addressing the impact of COVID-19 on vaccine hesitancy and potential fatigue in the general population.
Advertisement
Episodes in this series
- What How can we engage with patients to educate and emphasize the need and benefits associated with immunizing against pneumococcal disease?
- The COVID-19 pandemic has created a significant amount of vaccine fatigue and hesitancy. How do you identify these in your practice and how can they be overcome to achieve optimal vaccination rates?
- What impact do social determinants such as racial and ethnic disparities have on the vaccination rates of pneumococcal vaccines in underserved populations (health equity vs. equality)?
- What are the cost barriers that are present with pneumococcal vaccination and how can they be overcome?
- What does good collaboration look like between stakeholders in an effort to vaccinate in underserved populations?
Advertisement
Related to this article
Authors of a pharmacist-directed transitions-of-care study discuss what drives pneumococcal vaccine hesitancy and how pharmacists can build systematic vaccine screening into inpatient workflows.
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Tavapadon, First D1/D5 Agonist for Parkinson Disease
2
Ramantamig's 93.6% ORR and Outpatient CRS Control
3
CagriSema Tops Tirzepatide 5 mg for Weight Loss in REIMAGINE 5
4
Engineered Stem Cell Therapy Reverses New-Onset T1D in Mice by Reprogramming T Cells
5